4//SEC Filing
Patel Anish 4
Accession 0001967163-25-000004
CIK 0001672619other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:34 PM ET
Size
7.7 KB
Accession
0001967163-25-000004
Insider Transaction Report
Form 4
Patel Anish
CHIEF OPERATING OFFICER
Transactions
- Sale
Common Stock
2025-11-07$17.35/sh−6,054$105,039→ 270,587 total(indirect: See footnote) - Sale
Common Stock
2025-11-07$17.94/sh−613$10,995→ 269,974 total(indirect: See footnote)
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust").
- [F2]This transaction was executed in multiple trades at prices ranging from $16.825 to $17.8248. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]The shares are held by The Patel / Dong Family Trust.
- [F4]This transaction was executed in multiple trades at prices ranging from $17.835 to $18.265. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001967163
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:34 PM ET
- Size
- 7.7 KB